Allergic bronchopulmonary aspergillosis. A review of 3 cases.

##plugins.themes.academic_pro.article.main##

Leila Fekih
Leila Boussoffara
Hajer Ben Abdelghaffar
Soraya Fenniche
Ines Akrout
Hela Hassene
Dalenda Belhabib
Mohamed Lamine Megdiche

Abstract

Background: Allergic bronchopulmonary aspergillosis (ABPA) is a rare affection, initially described in 1952. Its pathophysiology incriminate several mecanisms in relation with the organism of the patient and the bronchial colonisation by the fongic agent.
Aim: To report three cases of ABPA.
Cases report: Three patients had been treated for ABPA in Ibn Nafiss department in Abderrahmen Mami hospital in Ariana. ABPA had been discovered in the three cases by a corticodependant asthma, refractory for different therapeutics. Positif diagnosis reposed in the 3 patients at 6 major and one minor criterion. Traitment was essentially based in corticotherapy.
Conclusion: Positif diagnosis of ABPA is actually well established, however, its traitement, although based on corticotherapy, remind not clearly codified. Association of antifongic treatment may improve the prognosis.

Keywords:

Aspergillus, aspergillosis, asthma, treatment, corticotherapy

##plugins.themes.academic_pro.article.details##

References

  1. Salez F, Lamblin C, Wallaert B. Aspergillose bronchopulmonaire allergique. Rev Mal Respir 2000; 17:265-78.
  2. Greenberger PA, Patterson R. Allergic bronchopulmonary aspergillosis and the evaluation of patient with asthma. J allergy clin Immunol 1988; 81:646-50.
  3. Schartz HJ, Greenberger PA. The prevalence of bronchopulmonary aspergillosis in patients with asthma, determined by serologic and radiologic criteria in patients at risk. J Lab Clin Med 1991;117:138-42.
  4. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002;110: 685-92.
  5. Germaud P, Renaudin K, Danner I et al. Aspergilloses bronchopulmonaires : les nouveaux enjeux. Rev Mal Respir 2001;18:257-66
  6. Baculard A, Khiati M, Briand M et al. Aspergillose et mucoviscidose : intérêt de l'apport local d'antifongiques par lavage bronchoalvéolaire. Arch Fr Pediatr 1983 ; 40 :109-112.
  7. Chauhan B, Santiago L, Hutcheson PS et al. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic broncho-pulmonary aspergillosis. J Allergy Clin Immunol 2000; 106:723-9.
  8. Daly P, Kavanagh K.Pulmonary aspergillosis: clinical presentation, diagnosis and therapy.Br J Biomed Sci 2001;58:197-205
  9. Ricketti AJ. Greenberger PA, Mintzer RA et al. Allergic bronchopulmonary aspergillosis. Arch Intern Med 1983; 143:1553-7.
  10. Rosenberg M, Patterson R, Roberts M, et al. The assessement of immunologic and clinical changes occuring during corticosteroid therapy for allergic broncho-pulmonary aspergillosis. Am J Med 1978;64:599-606.
  11. Sethi GR, Singhal KK. Pulmonary diseases and corticosteroids. Indian J Pediatr. 2008; 75:1045-56.
  12. Grant IW. Management of allergic broncho-pulmonary aspergillosis. Respir Med 1994;88,74-75.
  13. Salez F, Brichet A, Desurmont S et al. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest 1999; 116 :1665-8.
  14. Mulliez P, Croxo C, Roy Saint Georges F et al. Aspergillose bronchopulmonaire allergique traitée par voriconazole. Rev Mal Respir 2006; 23:93-4
  15. Bandres Gimeno R,Munoz Martinez MJ. Prolonged therapeutic response to voriconazole in a case of allergic bronchopulmonary aspergillosis. Arch Bronchopneumol 2007; 43:49-51.
  16. P Germaud, A Pipet. Aspergillose bronchopulmonaire allergique : nouvelles options thérapeutiques. Rev Mal Respir 2010 ; 27 :784- 785
  17. Randhawa I, Chin T, Nussbaum E. Resolution of corticoid-induced diabetes in allergic bronchopulmonary aspergillosis with omalizumab therapy: a novel approach J Asthma 2009; 46 : 445-447.
  18. Germaud P, Pipet A. Points de vue sur l'aspergillose bronchopulmonaire allergique. Rev Mal Respir 2007; 24:659-61
  19. Tillie-Leblond I, Tonnel AB. Allergic bronchopulmonary aspergillosis. Allergy 2005 ;60 :1004-13.